Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations
Sponsor: Hartford Hospital
Listed as NCT03191084, this EARLY_PHASE1 trial focuses on Marijuana Impairment and remains completed. Sponsored by Hartford Hospital, it has been updated 12 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Aug 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Aug 2024 [monthly]
Completed EARLY_PHASE1
-
Sep 2023 — Jul 2024 [monthly]
Completed EARLY_PHASE1
Status: Active Not Recruiting → Completed
-
Feb 2022 — Sep 2023 [monthly]
Active Not Recruiting EARLY_PHASE1
▶ Show 7 earlier versions
-
Mar 2021 — Feb 2022 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Unknown Status → Active Not Recruiting
-
Feb 2021 — Mar 2021 [monthly]
Unknown Status EARLY_PHASE1
Status: Recruiting → Unknown Status
-
Jan 2021 — Feb 2021 [monthly]
Recruiting EARLY_PHASE1
-
Feb 2019 — Jan 2021 [monthly]
Recruiting EARLY_PHASE1
-
Jun 2018 — Feb 2019 [monthly]
Recruiting EARLY_PHASE1
-
Mar 2018 — Jun 2018 [monthly]
Recruiting EARLY_PHASE1
-
Aug 2017 — Mar 2018 [monthly]
Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hartford Hospital
- Maastricht University
- Montana State University
- National Highway Traffic Safety Administration (NHTSA)
- National Institute on Drug Abuse (NIDA)
- The Mind Research Network
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .